Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SGLT2i”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Looking for participantsNCT06727409
What this trial is testing

Use of Clinical-trials and Simulation Models to Estimate Cost-effectiveness of Non-steroidal Mineralocorticoid Antagonists, RASi and SGLT2i as Triple Therapy With Type 2 Diabetes and Chronic Kidney Disease

Who this might be right for
Patients With Type 2 Diabetes
Chinese University of Hong Kong 82
Large-scale testing (Phase 3)Looking for participantsNCT07280585
What this trial is testing

STOP-PKD: SGLT2-inhibition to Improve Prognosis in Polycystic Kidney Disease

Who this might be right for
Polycystic Kidney, Autosomal Dominant
University of Cologne 420
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07060417
What this trial is testing

Vascular Effects of SGLT2i in Non-diabetic CKD

Who this might be right for
Non-diabetic Chronic Kidney Disease
VA Office of Research and Development 52
Post-approval studies (Phase 4)Study completedNCT06825156
What this trial is testing

Metabolic and Renal Outcomes in Cardiac Surgery Patients Receiving SGLT2 Inhibitors

Who this might be right for
Acute Kidney Injury
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 60
Post-approval studies (Phase 4)Not Yet RecruitingNCT07436663
What this trial is testing

Comparative Study Between (SGLT-2i) and (DPP-4i) in the Prevention of DIC

Who this might be right for
Breast Cancer
Tanta University 150
Not applicableActive Not RecruitingNCT05882071
What this trial is testing

Non-interventional Study (NIS) on Sodium-glucose Co-transporter-2 Inhibitors (SGLT2i) Use in France

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 547,150
Not applicableStudy completedNCT05465317
What this trial is testing

Evaluating Comparative Effectiveness of Empagliflozin in Type 2 Diabetes Population With and Without Chronic Kidney Disease

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 62,197
Not applicableNot Yet RecruitingNCT07044700
What this trial is testing

Real-world Comparative Effectiveness and Safety of Jardiance in Chinese Patients With Heart Failure of Reduced Ejection Fraction

Who this might be right for
Heart Failure of Reduced Ejection Fraction (HFrEF)
Boehringer Ingelheim 5,000
Not applicableStudy completedNCT03366181
What this trial is testing

SGLT2i As Anti Arrhythmic Therapy to Prevent Sudden Cardiac Deaths.

Who this might be right for
Heart FailureICDDiabetes Mellitus Type 2+1 more
University of Campania Luigi Vanvitelli 500
Large-scale testing (Phase 3)Not Yet RecruitingNCT07211802
What this trial is testing

CKM For Safe Use of SGLT2i in Type 1 Diabetes

Who this might be right for
Type 1 Diabetes (T1D)
University of California, San Diego 52
Not applicableLooking for participantsNCT06932081
What this trial is testing

Adult Congenital Heart Disease International EValuation of the Effectiveness of SGLT2i Registry

Who this might be right for
Adult Congenital Heart DiseaseCongenital Heart DiseaseSystemic Right Ventricle+5 more
Leiden University Medical Center 400
Post-approval studies (Phase 4)Study completedNCT03282136
What this trial is testing

SGLT2i and Incretin and CRTd.

Who this might be right for
Type 2 Diabetes MellitusHeart Failure
University of Campania Luigi Vanvitelli 500
Post-approval studies (Phase 4)Not Yet RecruitingNCT07108985
What this trial is testing

Effect of Add-on SGLT2i, TZD, or Combination Therapy in Type 2 Diabetes Patients on DPP4 Inhibitors

Who this might be right for
Diabetes Mellitus, Type 2HyperglycemiaInsulin Resistance
Yonsei University 100
Very early researchLooking for participantsNCT06430684
What this trial is testing

Feasibility Trial of Sodium-GLucose coTransporter 2 INhibitors in Pediatric Chronic KIDney DiSease

Who this might be right for
Chronic Kidney DiseasesPediatric Kidney Disease
Ann & Robert H Lurie Children's Hospital of Chicago 40
Post-approval studies (Phase 4)Active Not RecruitingNCT06933355
What this trial is testing

Acute Effects of SGLT2 Inhibitor on Kidney Allograft Oxygen Tension

Who this might be right for
Kidney Transplantation RecipientsMagnetic Resonance Imaging (MRI)Sodium-Glucose Transporter 2 Inhibitors+3 more
Odense University Hospital 8
Post-approval studies (Phase 4)Study completedNCT05233163
What this trial is testing

SGLT2 Inhibitors in Transthyretin Amyloid Cardiomyopathy

Who this might be right for
Transthyretin Amyloid Cardiomyopathy
Columbia University 15
Post-approval studies (Phase 4)Study completedNCT05735197
What this trial is testing

Effect of Dapagliflozin on Renal Outcomes and Bone Mineral Disease in Non-diabetic Chronic Kidney Disease Patients

Who this might be right for
Chronic Kidney DiseasesBone Diseases, Metabolic
Mansoura University 100
Large-scale testing (Phase 3)UnknownNCT06535529
What this trial is testing

Acetazolamide Versus Dapagliflozin in Acute Decompensated Heart Failure Patients

Who this might be right for
Acute Decompensated Heart Failure
Helwan University 60
Large-scale testing (Phase 3)Study completedNCT05998837
What this trial is testing

GLUcose Transport and REnalPROtection in Chronic Kidney Disease

Who this might be right for
Chronic Kidney DiseaseDiabetes Mellitus, Type 2Hypertension
IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy 34
Post-approval studies (Phase 4)Active Not RecruitingNCT06260059
What this trial is testing

Efficacy Of Sodium Glucose Transporter Inhibitor (SGLT2I) In Adult Patients With Congenital Heart Disease

Who this might be right for
Adult Congenital Heart DiseaseHeart Failure
Anita Saraf 40
Next Page